APP
GILD icon

Avantax Planning Partners’s Gilead Sciences GILD Stock Holding History

Avantax Planning Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$460K Sell
3,643
-1
-0% -$132 0.01% 301
2026
Q1 		$508K Buy
3,644
+12
+0.3% +$1.68K 0.01% 278
2025
Q4 		$446K Buy
3,632
+329
+10% +$40K 0.01% 295
2025
Q3 		$367K Sell
3,303
-373
-10% -$42.4K 0.01% 317
2025
Q2 		$408K Sell
3,676
-27
-0.7% -$2.87K 0.01% 298
2025
Q1 		$415K Buy
3,703
+44
+1% +$4.54K 0.01% 287
2024
Q4 		$338K Buy
3,659
+322
+10% +$29K 0.01% 313
2024
Q3 		$280K Sell
3,337
-338
-9% -$25.8K 0.01% 346
2024
Q2 		$252K Sell
3,675
-49
-1% -$3.27K 0.01% 393
2024
Q1 		$273K Sell
3,724
-658
-15% -$50.6K 0.01% 377
2023
Q4 		$355K Sell
4,382
-118
-3% -$9.18K 0.01% 274
2023
Q3 		$337K Buy
4,500
+644
+17% +$49.5K 0.01% 268
2023
Q2 		$297K Buy
3,856
+14
+0.4% +$1.12K 0.01% 296
2023
Q1 		$319K Sell
3,842
-137
-3% -$11.3K 0.01% 280
2022
Q4 		$342K Buy
3,979
+273
+7% +$21.6K 0.01% 281
2022
Q3 		$229K Buy
+3,706
New +$234K 0.01% 307
2022
Q2 		– Sell
-3,395
Closed -$202K – 355
2022
Q1 		$202K Buy
3,395
+566
+20% +$36.2K 0.01% 342
2021
Q4 		$205K Sell
2,829
-471
-14% -$32.4K 0.01% 335
2021
Q3 		$231K Hold
3,300
– – 0.01% 294
2021
Q2 		$227K Sell
3,300
-621
-16% -$41.5K 0.01% 294
2021
Q1 		$253K Sell
3,921
-834
-18% -$53.8K 0.01% 265
2020
Q4 		$277K Sell
4,755
-1,103
-19% -$66.6K 0.01% 238
2020
Q3 		$370K Buy
5,858
+915
+19% +$63.5K 0.02% 210
2020
Q2 		$380K Buy
4,943
+512
+12% +$39.2K 0.02% 197
2020
Q1 		$331K Sell
4,431
-4,971
-53% -$343K 0.02% 194
2019
Q4 		$611K Sell
9,402
-702
-7% -$45.7K 0.04% 150
2019
Q3 		$640K Buy
10,104
+339
+3% +$22.2K 0.04% 143
2019
Q2 		$659K Buy
9,765
+493
+5% +$32.4K 0.04% 138
2019
Q1 		$603K Buy
9,272
+1,982
+27% +$132K 0.04% 145
2018
Q4 		$456K Buy
7,290
+36
+0.5% +$2.52K 0.03% 154
2018
Q3 		$560K Sell
7,254
-1,496
-17% -$113K 0.04% 132
2018
Q2 		$620K Sell
8,750
-85
-1% -$6K 0.06% 118
2018
Q1 		$665K Sell
8,835
-156
-2% -$12.4K 0.06% 140
2017
Q4 		$644K Sell
8,991
-1,967
-18% -$149K 0.06% 143
2017
Q3 		$888K Sell
10,958
-10,091
-48% -$772K 0.07% 133
2017
Q2 		$1.49M Buy
21,049
+1,493
+8% +$99.3K 0.13% 80
2017
Q1 		$1.33M Sell
19,556
-173
-0.9% -$12.2K 0.12% 76
2016
Q4 		$1.41M Buy
+19,729
New +$1.47M 0.15% 64

Other funds holding GILD

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM

Avantax Planning Partners's GILD Position: Q2 2026 in Review

Avantax Planning Partners reduced its Gilead Sciences (GILD) stake by 0.03% in Q2 2026, selling an estimated $132 and leaving 3,643 shares worth $460K. The position accounts for 0.01% of the portfolio, ranked #301.

Avantax Planning Partners first reported a position in GILD in Q4 2016 and has held it in 38 quarters since. The position peaked at $1.49M in Q2 2017. 965 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Avantax Planning Partners held 3,643 shares of Gilead Sciences worth $460K as of Q2 2026.
  • Avantax Planning Partners sold 1 Gilead Sciences share in Q2 2026, an estimated $132.
  • Gilead Sciences made up 0.01% of Avantax Planning Partners's portfolio in Q2 2026, its #301 holding.
  • Avantax Planning Partners first reported a position in Gilead Sciences in Q4 2016 and has held it in 38 quarters since.
  • Avantax Planning Partners's Gilead Sciences position peaked at $1.49M in Q2 2017.
  • 965 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Avantax Planning Partners's 13F filing for Q2 2026, filed 28 Jul 2026.